PMID: 11338068May 8, 2001Paper

Results of a double-blind, randomized study to evaluate the efficacy and safety of Antibiophilus in patients with radiation-induced diarrhoea

European Journal of Gastroenterology & Hepatology
H UrbancsekK Neumann

Abstract

Gastrointestinal toxicity is frequently observed during radiotherapy for malignancies in the abdomen and pelvis. This study was performed to determine the efficacy and tolerability of Lactobacillus rhamnosus (Antibiophilus) in comparison to placebo in a double-blind trial design. Its aim was to determine any clinically relevant difference between Antibiophilus and placebo in terms of efficacy in patients suffering from mild to moderate diarrhoea induced by radiation therapy. The study was performed in two radiotherapy units in Hungary; the results are based on the data for 206 recruited patients. Based on statistical analysis, Antibiophilus patients showed superiority with respect to the number of bowel movements (P < 0.10) and faeces consistency ratings by the investigators (P < 0.05) at the study end. Statistical analysis of the patients' self-ratings with regard to diarrhoea grade and faeces consistency showed a statistically highly significant treatment-by-time interaction (P < 0.001) which was supported by the evidence of tendencies or P values below the nominal 5% level in the second half of this study. Overall, there was a highly favourable benefit/risk ratio in favour of Antibiophilus.

References

Dec 1, 1977·Biulleten' eksperimental'noĭ biologii i meditsiny·I G BogdanovM N Kolosov
Feb 1, 1990·Annals of Medicine·S L Gorbach
Feb 1, 1990·Annals of Medicine·A H Lichtenstein
Oct 1, 1984·International Journal of Radiation Oncology, Biology, Physics·S Chary, D H Thomson
Jan 1, 1983·Microbiology and Immunology·I KatoM Mutai
Feb 1, 1983·International Journal of Radiation Oncology, Biology, Physics·J A StrykerJ D Layser
Jan 1, 1996·Anti-cancer Drugs·H R Baillie-Johnson
Jul 1, 1997·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·M ResbeutT D N'Guyen
Mar 6, 1998·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·T AuerP Lukas
Aug 26, 1998·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·C Ippoliti

❮ Previous
Next ❯

Citations

May 23, 2009·Journal of Medicinal Food·Indu Pal KaurKanwaljit Chopra
Oct 13, 2006·Current Opinion in Gastroenterology·Paolo GionchettiMassimo Campieri
Jun 9, 2005·Journal of Clinical Gastroenterology·David C Montrose, Martin H Floch
Jul 31, 2004·Journal of Pediatric Hematology/oncology·Eric I Benchimol, David R Mack
Dec 21, 2004·Journal of Internal Medicine·A Sullivan, C E Nord
Mar 11, 2008·Applied and Environmental Microbiology·Sophie CoudeyrasChristiane Forestier
Aug 21, 2010·Canadian Journal of Microbiology·Sophie Coudeyras, Christiane Forestier
Jan 19, 2012·Nutrients·Asa Hakansson, Goran Molin
Mar 8, 2014·Current Gastroenterology Reports·Ali H HarbAla I Sharara
Apr 2, 2014·Nature Reviews. Gastroenterology & Hepatology·Martin Hauer-JensenH Jervoise N Andreyev
Nov 13, 2012·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Rachel J GibsonUNKNOWN Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (
Mar 13, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M G RedmanR S Phillips
Oct 4, 2005·Expert Opinion on Biological Therapy·Satya Prakash, Jasmine Bhathena
Mar 5, 2013·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Adeel HamadAlastair Forbes
Apr 6, 2005·Clinical Colorectal Cancer·Bridget E O'BrienAl B Benson
Jul 22, 2008·Hematology/oncology Clinics of North America·Mary L Hardy
Jun 23, 2009·Annals of the New York Academy of Sciences·Matthew A Ciorba, William F Stenson
Apr 9, 2013·Journal of Digestive Diseases·Gwilym James WebbAminda Niroshan De Silva
Jan 25, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·John K DibaiseJon A Vanderhoof
Aug 9, 2005·Gastroenterology Clinics of North America·Martin H Floch, David C Montrose
Apr 30, 2015·Disease-a-month : DM·Barry A Mizock
May 5, 2016·Nutrition and Cancer·Ai-Qun Yu, Lianqin Li
May 7, 2016·Integrative Cancer Therapies·Sona CiernikovaVladimir Zajac
Apr 5, 2008·The Journal of International Medical Research·G V ZuccottiM Giovannini
Jan 2, 2014·Therapeutic Advances in Chronic Disease·Rhodri Stacey, John T Green
Jan 24, 2018·The Cochrane Database of Systematic Reviews·Theresa A LawrieH Jervoise N Andreyev
Aug 23, 2002·The American Journal of Gastroenterology·Pietro DeliaGiuseppe Famularo
May 27, 2004·British Journal of Cancer·C McGoughH J N Andreyev
Aug 24, 2018·Integrative Cancer Therapies·Michael Thomsen, Luis Vitetta
Sep 1, 2018·The Cochrane Database of Systematic Reviews·Dang WeiRob Jpm Scholten
Nov 10, 2007·Current Gastroenterology Reports·Eamonn M M Quigley
Jun 11, 2008·Journal of Clinical Gastroenterology·Martin H FlochLevinus A Dieleman
Jul 17, 2008·Current Gastroenterology Reports·Eamonn M M Quigley

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.